You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
McKesson
AstraZeneca
McKinsey
Colorcon
Johnson and Johnson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Mayne Pharma Inc Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for MAYNE PHARMA INC, and what generic and branded alternatives to MAYNE PHARMA INC drugs are available?

MAYNE PHARMA INC has twenty-three approved drugs.

There is one tentative approval on MAYNE PHARMA INC drugs.

Summary for Mayne Pharma Inc
US Patents:0
Tradenames:20
Ingredients:20
NDAs:23

Drugs and US Patents for Mayne Pharma Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma Inc NYSTATIN nystatin POWDER;TOPICAL 065203-001 Jul 15, 2004 AT RX No Yes   Start Trial   Start Trial
Mayne Pharma Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride SOLUTION;ORAL 204092-001 Jun 5, 2014 AA RX No No   Start Trial   Start Trial
Mayne Pharma Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 091313-005 Apr 29, 2016 AB RX No No   Start Trial   Start Trial
Mayne Pharma Inc OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 090177-004 Oct 20, 2008 AA RX No No   Start Trial   Start Trial
Mayne Pharma Inc DOXYCYCLINE doxycycline CAPSULE;ORAL 209396-003 Sep 29, 2017 AB RX No No   Start Trial   Start Trial
Mayne Pharma Inc DOFETILIDE dofetilide CAPSULE;ORAL 207058-002 Jun 6, 2016 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
McKinsey
Express Scripts
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.